Ralf Weiskirchen

Dr. Ralf Weiskirchen is a Full Professor and the Head of the Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC) at RWTH University Aachen. He obtained his Ph.D. from the Institute of Biochemistry, Medical Faculty, University of Cologne, in 1994. With a strong academic background and extensive research experience, he has expertise in various biological disciplines, such as molecular biology, microbiology, biochemistry, pharmacology, and genetics. His primary research focus is on understanding the molecular mechanisms involved in the development of hepatic diseases. Specifically, he investigates the immunobiology of the liver, ranging from healthy states to states of chronic inflammation, fibrosis, cirrhosis, and cancer. He places special emphasis on studying cytokine/chemokine activities and identifying new laboratory biomarkers for specific conditions. In recognition of his contributions, he was selected for inclusion in the 2024 and 2025 Highly Cited Researchers lists from Clarivate.